31
October
The research of Lian Yu and Mel de Villiers, Professors in the Pharmaceutical Sciences Division, will benefit from an exceptional commitment from AstraZeneca towards the school’s Pharmaceutical Sciences Graduate Program.
AstraZeneca has generously agreed to provide three years of support towards research to study the stability and stabilization of amorphous drugs. The project will build on the discovery from the Yu and de Villiers research groups that surface crystallization is a major failure mechanism for amorphous drugs and that nanometer thin coatings effectively inhibit surface crystallization.